Navelbine Interactions
There are 506 drugs known to interact with Navelbine (vinorelbine), along with 6 disease interactions. Of the total drug interactions, 76 are major, 412 are moderate, and 18 are minor.
- View all 506 medications that may interact with Navelbine
- View Navelbine disease interactions (6)
Most frequently checked interactions
View interaction reports for Navelbine (vinorelbine) and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- acetaminophen
- Advair HFA (fluticasone / salmeterol)
- Afinitor (everolimus)
- albuterol
- albuterol / ipratropium
- carboplatin
- cisplatin
- dexamethasone
- Fentanyl Transdermal System (fentanyl)
- furosemide
- gabapentin
- Gemzar (gemcitabine)
- Herceptin (trastuzumab)
- levothyroxine
- lorazepam
- Lyrica (pregabalin)
- megestrol
- naproxen
- Neupogen (filgrastim)
- Nexium (esomeprazole)
- ondansetron
- Plavix (clopidogrel)
- prednisone
- Synthroid (levothyroxine)
- tramadol
- Vitamin D3 (cholecalciferol)
- Xeloda (capecitabine)
- Zofran (ondansetron)
- Zometa (zoledronic acid)
Navelbine disease interactions
There are 6 disease interactions with Navelbine (vinorelbine) which include:
- pulmonary dysfunction
- hepatic dysfunction
- infections
- myelosuppression
- gastrointestinal disorders
- peripheral neurotoxicity
Report options
QR code containing a link to this page
More about Navelbine (vinorelbine)
- Navelbine consumer information
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.